Media ReleaseFrom: University of Technology Sydney (UTS)
An international research consortium studying 520,000 individuals from around the world has identified 22 new genetic risk factors for stroke, thus tripling the number of gene regions known to affect stroke risk. The results demonstrate shared genetic influences with multiple related vascular conditions, especially blood pressure, but also coronary artery disease, venous thromboembolism and others. Linking these results with extensive biological databases provides novel clues on stroke mechanisms and illustrates the potential of genetics to identify drug targets for stroke therapy.
The results of the largest genetic study on stroke thus far are published online in the journal Nature Genetics. The study was based on DNA samples of 520,000 European, North and South American, Asian, African and Australian participants, of whom 67,000 had a stroke. These were derived from 29 large studies.
From the millions of genetic variants analysed, 32 independent genomic regions were shown to be associated with stroke, of which two thirds are novel.
The study was conducted by members of MEGASTROKE, a large-scale international collaboration launched by the International Stroke Genetics Consortium, a multi-disciplinary collaborative of experts in stroke genetics who have been working together for the past 10 years. MEGASTROKE members include research groups from Germany, France, the UK, Japan, USA, Iceland, Spain, Switzerland, Italy, Belgium, the Netherlands, Denmark, Sweden, Norway, Finland, Estonia, Poland, Singapore, Australia and Canada.
“Because the extent to which individual variants modify stroke risk is very small, it required a large number of subjects to discover these variants. Our group has leveraged extensive datasets set up by numerous researchers over the past few years,” says Martin Dichgans, professor of neurology and director at the Institute for Stroke and Dementia Research, Ludwig-Maximilians-University in Munich, and one of the leaders of the current study.
“We can’t overstate the importance of international collaboration across different ethnic origins when studying genetics of complex, common diseases like stroke. This large-scale collaboration across continents has been a game changer,” says Stephanie Debette, Professor of Epidemiology and Neurologist at University of Bordeaux and Bordeaux University Hospital, and another leader of the study.
Stroke is the second most common cause of both death and disability-adjusted life-years worldwide, but its molecular mechanisms remain poorly understood, which makes developing new treatments challenging. This study provides extensive new insights on the biology and pathways leading to stroke.
Stroke can originate from alterations in various parts of the vasculature including large arteries, small arteries, the heart and the venous system and the researchers found genetic risk factors implicated in each of these mechanisms. They showed that some genetic risk factors contribute to specific mechanisms and others to stroke susceptibility at large. They also found shared genetic influences between stroke caused by vessel occlusion (the most common cause of stroke) and stroke caused by rupture of a blood vessel (the most catastrophic cause of stroke), often thought to have opposite mechanisms.
When the researchers took a closer look at the genomic areas pinpointed in the study, they noticed several overlap with genomic areas known to be implicated in related vascular conditions such as atrial fibrillation, coronary artery disease, venous thrombosis or vascular risk factors, especially elevated blood pressure, and less so hyperlipidemia.
By adding data on gene expression, protein expression and other characteristics in multiple cell types and tissues compiled by their co-investigators, the researchers obtained first insights into the specific genes, molecular pathways, and cell and tissue types through which the new genetic risk factors cause stroke.
The researchers further found that the genes they identified are enriched in drug targets for antithrombotic therapy, used to re-open occluded blood vessels in patients with acute stroke or to prevent vascular events including stroke. These findings illustrate the potential of genetics for drug discovery, says Professor Jane Maguire, a researcher from University of Technology Sydney and co-author of the study.
“These genetic findings represent a first step towards developing personalised, evidence-based treatments for this very complex disease. They provide evidence for several novel biological pathways involved in stroke that may lead to the discovery of new drug targets,” says Professor Maguire, a former chair of the International Stroke Genetics Consortium.
These interesting findings – linking stroke with multiple other disease states and with dysregulation of genes, proteins, and molecular pathways in specific cell types and organs - were generated using novel bioinformatics approaches that utilize and combine information from various international biological databases. Such datasets are invaluable in situations like this when tissue samples from patients are not readily available, underscoring the importance of data sharing, says Dr Elizabeth Holliday, Associate Professor of Biostatistics at the University of Newcastle, Australia.
The study received financial support from multiple sources, including from the National Health and Medical Research Council (NHMRC).
Multi-ancestry genome-wide association study of 520,000 subjects identifies 32 loci associated with stroke and stroke subtypes (2018). Rainer Malik, Ganesh Chauhan, Matthew Traylor, Muralidharan Sargurupremraj et al. Nature Genetics. doi: http://dx.doi.org/10.1038/s41588-018-0058-3.